Merck KGaA Raises Voting‑Rights Stake to 8% – No Control Change Announced
Merck KGaA lifts its voting‑rights stake to 8%, meeting German disclosure rules—no control shift, just transparent ownership for investors.
3 minutes to read
Dr. Sarah Winters
Medical Affairs Correspondent
Medical doctor turned healthcare journalist with 11 years of experience covering pharmaceutical developments, medical device innovation, and healthcare policy. Former emergency medicine physician who transitioned to journalism to bridge the gap between clinical practice and public health reporting. Specializes in drug approvals, clinical trial analysis, and the intersection of technology and patient care.
AI Author, more information here
China’s Healthcare Market: BCI Regulation, TCM Standards and Biopharma ETF Surge Drive Investor Confidence
China’s latest market snapshot: HK equities edge up, private hospitals rally, BCI device approvals streamlined, and biopharma ETF inflows hit 12.4%.
- SHANGHAI FOSUN PHARMACEUTI-H
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read
CVS Health Boosts AI Governance & Menopause Care: Choice Hotels & Women’s Health Initiative Announced
CVS Health expands tech and health strategy: Ali Keshavarz joins Choice Hotels board to boost AI analytics, while a new menopause care initiative pushes for advanced clinical training, integrated pathways, and policy advocacy.
3 minutes to read
Medtronic PLC Q4 2025/26 Results: 2.8% Revenue Rise, EPS Surpasses Forecast
Medtronic’s Q4 2025/26 earnings beat estimates with a 2.8% revenue lift, strong EPS growth, and a 0.5% dividend hike—insights into its cardiovascular, diabetes, and drug‑delivery outlook.
2 minutes to read
EISAI’s Breakthrough HGG Drug Gains FDA Designations, Boosting Neuro‑Oncology Hope
Discover EISAI’s breakthrough glioma therapy—FDA‑designated, biomarker‑driven, and showing early disease stabilization with a favorable safety profile.
3 minutes to read
Labcorp Files SEC 8‑K & Announces Q2 2026 Earnings Release – Key Highlights
Labcorp Holdings Inc. (LH) confirms Q2 2026 earnings will be released July 30, highlighting regulatory compliance, global reach, and insider activity.
3 minutes to read
Intuitive Surgical’s da Vinci 5 Drives 11,000‑Unit Surge, Reinforcing Market Leadership
Intuitive Surgical’s da Vinci 5 drives 11,000‑unit growth, boosting revenue, earnings and market leadership in surgical robotics.
3 minutes to read
Siemens Healthineers Leads Oncology Pre‑Clinical Research, Driving Faster, Safer Cancer Therapies
Siemens Healthineers leads oncology pre‑clinical research, delivering advanced imaging, PK/PD, biomarker, and toxicology services that speed cancer drug development and improve patient outcomes.
3 minutes to read
UnitedHealth Q2 Earnings: 20% EPS Surge, 39% Full‑Year Upside
UnitedHealth Group (UNH) projects a 20% Q2 EPS jump and 39% yearly rise, with Optum Health driving margin recovery and robust investor confidence.
3 minutes to read
Novonesis Analyst Upgrades: Target Prices Rise to 480–490 DKK
Novonesis analysts lift target prices—Jefferies, BørsHus and Deutsche Bank now forecast up to 490 kr, backing a bullish stance amid modest share gains.
One minute to read